2/6/2024 | CV | Market Commentary: High-grade convertible notes in focus; Lumentum gains pre-earnings; Rocket Lab higher
|
2/6/2024 | CV | Market Commentary: Morning Commentary: High-grade convertible notes in focus in early secondary trading
|
12/20/2023 | CV | Market Commentary: Pre-holiday trading slows; Welltower paper declines; Farfetch convertibles swing higher
|
12/20/2023 | CV | Market Commentary: Morning Commentary: Trading slows; Farfetch convertibles down; Welltower paper declines
|
10/12/2023 | CV | Market Commentary: Rivian convertible notes weaken; Insulet down outright, up on hedge amid Ozempic hit
|
10/2/2023 | CV | Market Commentary: NextEra convertibles in focus as stock collapse continues; high-grade names weaker
|
8/2/2023 | BKBWCVGNIGLM | Welltower cuts net leverage ratio down to 5.62x, to tackle 2024 debt
|
7/14/2023 | CV | Market Commentary: Investment-grade convertible bonds active; Beyond Meat notes trade higher
|
7/14/2023 | CV | Market Commentary: Morning Commentary: Investment-grade convertible notes active in early trading
|
7/10/2023 | CV | Market Commentary: Fisker privately places convertible notes; Lucid, Rivian rise; PPL, Welltower weaker
|
6/23/2023 | CV | Market Commentary: Starwood convertible notes in focus, contract on debut; Ventas, Welltower below par
|
6/12/2023 | CV | Market Commentary: Lumentum convertibles on deck; Ventas Realty improves; Lucid gains; Welltower active
|
6/12/2023 | CV | Market Commentary: Morning Commentary: Ventas Realty, Welltower convertible notes active in early trading
|
6/9/2023 | CV | Market Commentary: Ventas convertibles flat on hedge; Bread Financial soars; Welltower active; Vail gains
|
5/31/2023 | CV | Market Commentary: Investment-grade convertible notes dominate quiet trading session; Middleby active
|
5/24/2023 | CV | Market Commentary: Duke, CMS, Welltower hit new lows; Sarepta, PTC Therapeutics down outright, up on swap
|
5/23/2023 | CV | Market Commentary: Integra LifeSciences convertible notes in focus on product recall; Welltower below par
|
5/22/2023 | CV | Market Commentary: Welltower, PPL convertible notes weaken; TripAdvisor active; Wayfair closes below par
|
5/22/2023 | CV | Market Commentary: Morning Commentary: Convertibles market quiet early; Welltower notes drop below par
|
5/11/2023 | CV | Welltower greenshoe exercised in full, lifts 2.75% five-year exchangeables to $1.04 billion
|
5/10/2023 | CV | Market Commentary: Wayfair convertible notes volatile outright, up on hedge on debut; high-grade notes gain
|
5/9/2023 | CV | Market Commentary: Wayfair convertibles on tap; Welltower flat on debut; TransMedics, Granite notes soar
|
5/9/2023 | CV | Market Commentary: Morning Commentary: Wayfair on tap; Welltower, TransMedics, Granite hit aftermarket
|
5/9/2023 | CV | New Issue: Welltower prices upsized $900 million five-year exchangeable notes at 2.75%, up 25%
|
5/8/2023 | CV | Market Commentary: Welltower, TransMedics convertible notes offerings emerge; Zscaler up on earnings
|
5/8/2023 | BKCVGNIG | Moody’s rates Welltower convertible Baa1
|
5/8/2023 | CV | Market Commentary: Morning Commentary: Welltower, TransMedics convertible notes offerings emerge
|
5/8/2023 | CV | Welltower talks $750 million five-year exchangeable notes to yield 2.25%-2.75%, up 22.5%-27.5%
|
2/27/2019 | CVLM | Welltower elects to convert all 6.5% series I preferreds to stock
|
2/26/2019 | CV | Market Commentary: LivePerson on tap; Danaher’s mandatory convertible preferreds eyed; Nio gains outright
|
2/26/2019 | CV | Market Commentary: Morning Commentary: Danaher’s mandatory convertible preferreds eyed; Nio gains outright
|